The new Houston site, Lilly's eighth U.S. manufacturing facility announced since 2020, will focus on domestic production of small molecule synthetic medicines
Investment will support AstraZeneca’s ambition to reach $80 billion revenue by 2030, with 50% generated in the US
ISG acknowledged Indegene's strengths in implementing holistic creative workflows, interoperability via robust integration with tech ecosystems
ekincare has raised a total funding of $22M since 2015 till date
David joins HCTI with a distinguished career of over 22 years of corporate finance experience
Previously, Sujatha has held leadership positions at prominent organizations, including Publicis Sapient, Infinite Computer Solutions, and Capgemini
Illexcor is developing a first-in-class oral drug that directly targets the root cause of SCD
The PIPE offering consists of 36,190,476 units
The product will be marketed by Dr. Reddy's
The proceeds from its fresh issuance to the extent of Rs 107 crore will be utilized for funding the capital expenditure requirements
Subscribe To Our Newsletter & Stay Updated
